CannaPharmaRX CEO Dean Medwid resigns for personal reasons; board searches for successor

CANNAPHARMARX, INC.

Dean Medwid stepped down as CEO effective September 9, 2024, for personal reasons.
No disagreement between Medwid and the company on operations, policies, or practices.
Board of Directors has begun search for a replacement CEO.
In the interim, board will collectively manage day-to-day operations.
Company expects a smooth transition with minimal operational interruption.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dean Medwid

Chief Executive Officer

CPMD · CANNAPHARMARX, INC.

Filed: September 17, 2024, 7:59 PM ET

Dean Medwid stepped down as the Chief Executive Officer (“CEO”) of CannaPharmaRX, Inc. (the “Company”) for personal reasons.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dean Medwid resigned as Chief Executive Officer at CANNAPHARMARX, INC..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

Dean Medwid stepped down as the Chief Executive Officer (“CEO”) of CannaPharmaRX, Inc. (the “Company”) for personal reasons.

View on SEC.gov

CANNAPHARMARX, INC. filing history →

Source: SEC EDGAR

accession 0001683168-24-006456

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.